Purdue Research Foundation

University of Utah Research Foundation

Christopher Galliford

Philip Stewart Low

Jindrich Henry Kopecek

Stewart Andrew Low

Jiyan Yang

Aspects of the present disclosure generally relate to compounds for targeting and healing bone fractures. Some of these compounds include a negatively charged oligopeptide comprising an acidic oligopeptide, a linker, which may be hydrolyzable or may be a substrate for the protease cathepsin K, and at least one molecule that promotes bone healing. In some compounds the molecule that promotes bone healing is an anabolic compound that inhibits GSK3&#x3b2;, in some compounds the molecule that promotes the healing of bone fracture is a pro-inflammatory agent such as PGE1. Other embodiments include methods of treating a bone fracture comprising administering a therapeutic amount of any one of the compounds disclosed herein.

Growing community of inventors

Silver Spring, MD, United States of America

Christopher Galliford